Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chelby Wakefield"'
Autor:
Juan Carlo Avalon, Jacob Fuqua, Tyler Miller, Seth Deskins, Chelby Wakefield, Austin King, Sonya Inderbitzin-Brooks, Christopher Bianco, Lauren Veltri, Wei Fang, Michael Craig, Abraham Kanate, Kelly Ross, Midhun Malla, Brijesh Patel
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Background Ibrutinib is a Bruton’s tyrosine kinase inhibitor used in the treatment of hematological malignancies. The most common cardiotoxicity associated with ibrutinib is atrial arrhythmia (atrial fibrillation and flutter). It is known
Externí odkaz:
https://doaj.org/article/dd55526f958e4bdbbb25c6d0cb0df70b
Publikováno v:
BMJ case reports. 14(11)
We present here the second documented case of severe immune checkpoint inhibitor-induced myocarditis successfully treated with abatacept. The patient was started on pembrolizumab for stage IIIA malignant melanoma, and after the first dose was admitte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baa6be9cbe3a558d8c63069eb12406e2
https://pubmed.ncbi.nlm.nih.gov/34728505
https://pubmed.ncbi.nlm.nih.gov/34728505
Autor:
Michael Craig, Austin King, Sonya Inderbitzin-Brooks, Abraham S. Kanate, Midhun Malla, Seth Deskins, Brijesh Patel, Juan Carlo Avalon, Jacob Fuqua, Christopher Bianco, Tyler Miller, Chelby Wakefield, Wei Fang, Lauren Veltri, Kelly G. Ross
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-8 (2021)
Cardio-oncology
Cardio-oncology
Background Ibrutinib is a Bruton’s tyrosine kinase inhibitor used in the treatment of hematological malignancies. The most common cardiotoxicity associated with ibrutinib is atrial arrhythmia (atrial fibrillation and flutter). It is known that pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5719f963d5c3d7ac40faba74e701d91
https://doaj.org/article/dd55526f958e4bdbbb25c6d0cb0df70b
https://doaj.org/article/dd55526f958e4bdbbb25c6d0cb0df70b
Autor:
Austin King, Seth Deskins, Juan Carlo Avalon, Tyler Miller, Sonya Inderbitzin-Brooks, Abraham S. Kanate, Michael Craig, Chelby Wakefield, Brijesh Patel, Midhun Malla, Jacob Fuqua, Christopher Bianco, Lauren Veltri, Kelly G. Ross, Wei Fang
Background: Ibrutinib is a Bruton’s tyrosine kinase inhibitor used in the treatment of hematological malignancies. The most common cardiotoxicity associated with ibrutinib is atrial arrhythmia (atrial fibrillation and flutter). It is known that pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::948140d7dfdd314f4b06ca31543e716e
https://doi.org/10.21203/rs.3.rs-401031/v1
https://doi.org/10.21203/rs.3.rs-401031/v1
Autor:
Steven Rollins, Chelby Wakefield, Michael Craig, Aaron Cumpston, Mehdi Hamadani, Abraham S. Kanate, Sijin Wen, Carl T. Shultz, Lauren Veltri, Kelly G. Ross
Publikováno v:
Transplantation and Cellular Therapy. 27:S228-S229
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44bf388c862bfceb9e67c0ae078aff01
https://doi.org/10.1016/s2666-6367(21)00283-9
https://doi.org/10.1016/s2666-6367(21)00283-9
Autor:
Juan Carlo Avalon, Jacob Fuqua, Seth Deskins, Sonya Inderbitzin-Brooks, Chelby Wakefield, Austin King, Tyler Miller, Lauren Veltri, Kelly Ross, Abraham Kanate, Michael Craig, Christopher Bianco, Midhun Malla, Brijesh Patel
Publikováno v:
Journal of the American College of Cardiology. 77:3317
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81cbf481c7135c9603bd39ca6b260115
https://doi.org/10.1016/s0735-1097(21)04671-4
https://doi.org/10.1016/s0735-1097(21)04671-4